153 related articles for article (PubMed ID: 38292873)
1. Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database.
Xie L; Zhang Z
Front Immunol; 2024; 15():1334992. PubMed ID: 38292873
[TBL] [Abstract][Full Text] [Related]
2. Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study.
Lian HM; Wu JL; Liufu WJ; Yu TT; Niu SQ; Bao Y; Peng F
Cancer Immunol Immunother; 2024 Feb; 73(3):55. PubMed ID: 38366287
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysis.
Li J; Gong Y; Diao P; Huang Q; Wen Y; Lin B; Cai H; Tian H; He B; Ji L; Guo P; Miao J; Du X
Radiat Oncol; 2018 Jan; 13(1):12. PubMed ID: 29357883
[TBL] [Abstract][Full Text] [Related]
5. Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
Wang X; Lu X; Chen J; Yi H; Lan Q
BMC Surg; 2023 Oct; 23(1):299. PubMed ID: 37789291
[TBL] [Abstract][Full Text] [Related]
6. The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ-Ⅲ esophageal cancer: a SEER-based demographic analysis.
Lv H; Chao C; Wang B; Wang Z; Qian Y; Zhang X
Cancer Med; 2021 Dec; 10(23):8483-8496. PubMed ID: 34800005
[TBL] [Abstract][Full Text] [Related]
7. Effect of Marital Status on the Survival of Patients With Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Study.
Wang S; Chen L; Chen D; Chao J; Shao Y; Tang K; Chen W
Cancer Control; 2021; 28():10732748211066309. PubMed ID: 34910613
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes of neoadjuvant and adjuvant chemoradiotherapy for locally advanced adenocarcinoma of the oesophagogastric junction: a retrospective cohort study using the SEER database.
Zhang F; Feng X; Li Y; Yan J; Zhang Z; Song X
J Gastrointest Oncol; 2022 Feb; 13(1):26-39. PubMed ID: 35284136
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy vs radiotherapy for non-surgical locally advanced laryngeal squamous cell carcinoma patients: a propensity score-matched study and practical nomogram construction.
Zhang Y; Wang Z; Zheng Y
Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1449-1456. PubMed ID: 38158418
[TBL] [Abstract][Full Text] [Related]
10. Impact of chemoradiotherapy on the survival of unresectable locally advanced pancreatic cancer: a retrospective cohort analysis.
Wang ZM; Ma HB; Meng Y
BMC Gastroenterol; 2023 Apr; 23(1):107. PubMed ID: 37020202
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy Is Superior to Radiotherapy Alone in Esophageal Cancer Patients Older Than 65 Years: A Propensity Score-Matched Analysis of the SEER Database.
Xia X; Gao Q; Ge X; Liu Z; Di X; Sun X; Yang Y
Front Oncol; 2021; 11():736448. PubMed ID: 34557416
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation.
Wu J; Huang M; Wu Y; Hong Y; Cai L; He R; Luo Y; Wang P; Huang M; Lin J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8897-8912. PubMed ID: 37154929
[TBL] [Abstract][Full Text] [Related]
13. Survival differences between chemotherapy and chemoradiotherapy in metastatic esophageal cancer: a propensity score-matched study based on the SEER database.
Shao Y; Zhang M; Ye L; Chen D; Wu QC; Zhang C
Ann Palliat Med; 2021 Apr; 10(4):3826-3835. PubMed ID: 33691433
[TBL] [Abstract][Full Text] [Related]
14. Surgery Adherence and Survival Outcomes in Patients With Locally Advanced (IIA-IVA) Cancer of the Lower Esophagus: A SEER Database-Based Study.
Liu J; Chen H; Wu C
Am Surg; 2024 Jun; 90(6):1463-1474. PubMed ID: 38532292
[TBL] [Abstract][Full Text] [Related]
15. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.
Hong JC; Murphy JD; Wang SJ; Koong AC; Chang DT
Ann Surg Oncol; 2013 Nov; 20(12):3999-4007. PubMed ID: 23800897
[TBL] [Abstract][Full Text] [Related]
16. [Long-term efficacy and safety of simultaneous integrated boost radiotherapy in non-operative esophageal squamous cell carcinoma: a multicenter retrospective data analysis (3JECROG R-05)].
Wang XM; Wang L; Wang X; Chen JQ; Li C; Zhang WC; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Lu N; Han C; Pang QS; Wang P; Sun XC; Zhang KX; Li GF; Li L; Liu ML; Wang YD; Qiao XY; Zhu SC; Zhou ZM; Zhao YD; Xiao ZF
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):889-896. PubMed ID: 34407597
[No Abstract] [Full Text] [Related]
17. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of locally advanced esophageal cancer: a population-based analysis.
Qi WX; Chen C; Zhao S; Chen J
Int J Clin Oncol; 2022 Feb; 27(2):340-347. PubMed ID: 34731352
[TBL] [Abstract][Full Text] [Related]
18. Comparison between radical surgery and chemoradiotherapy in patients with cervical esophageal cancer: a propensity score matched analysis.
Qi K; Lin G; Liu H; Zhang X; Chen Z; Li J
BMC Surg; 2023 May; 23(1):119. PubMed ID: 37170089
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis.
Li J; Jia Y; Cheng Y; Wang J
Cancer Med; 2020 Jul; 9(14):5025-5034. PubMed ID: 32441890
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.
Chen X; Liu G; Wang K; Chen G; Sun J
Oncotarget; 2017 Jul; 8(29):47831-47840. PubMed ID: 28599299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]